218 related articles for article (PubMed ID: 30521808)
1. Cardiovascular development and survival require Mef2c function in the myocardial but not the endothelial lineage.
Materna SC; Sinha T; Barnes RM; Lammerts van Bueren K; Black BL
Dev Biol; 2019 Jan; 445(2):170-177. PubMed ID: 30521808
[TBL] [Abstract][Full Text] [Related]
2. Requirement of the MADS-box transcription factor MEF2C for vascular development.
Lin Q; Lu J; Yanagisawa H; Webb R; Lyons GE; Richardson JA; Olson EN
Development; 1998 Nov; 125(22):4565-74. PubMed ID: 9778514
[TBL] [Abstract][Full Text] [Related]
3. Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses.
Vong LH; Ragusa MJ; Schwarz JJ
Genesis; 2005 Sep; 43(1):43-8. PubMed ID: 16106363
[TBL] [Abstract][Full Text] [Related]
4. MEF2C regulates outflow tract alignment and transcriptional control of Tdgf1.
Barnes RM; Harris IS; Jaehnig EJ; Sauls K; Sinha T; Rojas A; Schachterle W; McCulley DJ; Norris RA; Black BL
Development; 2016 Mar; 143(5):774-9. PubMed ID: 26811383
[TBL] [Abstract][Full Text] [Related]
5. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.
Kang Y; Kim J; Anderson JP; Wu J; Gleim SR; Kundu RK; McLean DL; Kim JD; Park H; Jin SW; Hwa J; Quertermous T; Chun HJ
Circ Res; 2013 Jun; 113(1):22-31. PubMed ID: 23603510
[TBL] [Abstract][Full Text] [Related]
6. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis reveals distinct and overlapping functions of Mef2c and Mef2d during cardiogenesis in Xenopus laevis.
Guo Y; Kühl SJ; Pfister AS; Cizelsky W; Denk S; Beer-Molz L; Kühl M
PLoS One; 2014; 9(1):e87294. PubMed ID: 24489892
[TBL] [Abstract][Full Text] [Related]
8. Essentiality of Regulator of G Protein Signaling 6 and Oxidized Ca
Chakravarti B; Yang J; Ahlers-Dannen KE; Luo Z; Flaherty HA; Meyerholz DK; Anderson ME; Fisher RA
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079565
[TBL] [Abstract][Full Text] [Related]
9. Critical role of phosphodiesterase 2A in mouse congenital heart defects.
Assenza MR; Barbagallo F; Barrios F; Cornacchione M; Campolo F; Vivarelli E; Gianfrilli D; Auletta L; Soricelli A; Isidori AM; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2018 May; 114(6):830-845. PubMed ID: 29409032
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects.
Kodo K; Nishizawa T; Furutani M; Arai S; Ishihara K; Oda M; Makino S; Fukuda K; Takahashi T; Matsuoka R; Nakanishi T; Yamagishi H
Circ J; 2012; 76(7):1703-11. PubMed ID: 22498567
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF.
Bi W; Drake CJ; Schwarz JJ
Dev Biol; 1999 Jul; 211(2):255-67. PubMed ID: 10395786
[TBL] [Abstract][Full Text] [Related]
12. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality.
Parlakian A; Tuil D; Hamard G; Tavernier G; Hentzen D; Concordet JP; Paulin D; Li Z; Daegelen D
Mol Cell Biol; 2004 Jun; 24(12):5281-9. PubMed ID: 15169892
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin signals through integrin α5β1 to regulate cardiovascular development in a cell type-specific manner.
Chen D; Wang X; Liang D; Gordon J; Mittal A; Manley N; Degenhardt K; Astrof S
Dev Biol; 2015 Nov; 407(2):195-210. PubMed ID: 26434918
[TBL] [Abstract][Full Text] [Related]
14. HAND1 loss-of-function within the embryonic myocardium reveals survivable congenital cardiac defects and adult heart failure.
Firulli BA; George RM; Harkin J; Toolan KP; Gao H; Liu Y; Zhang W; Field LJ; Liu Y; Shou W; Payne RM; Rubart-von der Lohe M; Firulli AB
Cardiovasc Res; 2020 Mar; 116(3):605-618. PubMed ID: 31286141
[TBL] [Abstract][Full Text] [Related]
15. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development.
Takeuchi JK; Mileikovskaia M; Koshiba-Takeuchi K; Heidt AB; Mori AD; Arruda EP; Gertsenstein M; Georges R; Davidson L; Mo R; Hui CC; Henkelman RM; Nemer M; Black BL; Nagy A; Bruneau BG
Development; 2005 May; 132(10):2463-74. PubMed ID: 15843409
[TBL] [Abstract][Full Text] [Related]
16. FoxO1 is required in endothelial but not myocardial cell lineages during cardiovascular development.
Sengupta A; Chakraborty S; Paik J; Yutzey KE; Evans-Anderson HJ
Dev Dyn; 2012 Apr; 241(4):803-13. PubMed ID: 22411556
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis.
Gerety SS; Anderson DJ
Development; 2002 Mar; 129(6):1397-410. PubMed ID: 11880349
[TBL] [Abstract][Full Text] [Related]
18. Bcar1/p130Cas is essential for ventricular development and neural crest cell remodelling of the cardiac outflow tract.
Mahmoud M; Evans I; Wisniewski L; Tam Y; Walsh C; Walker-Samuel S; Frankel P; Scambler P; Zachary I
Cardiovasc Res; 2022 Jun; 118(8):1993-2005. PubMed ID: 34270692
[TBL] [Abstract][Full Text] [Related]
19. Inositol 1,4,5-trisphosphate receptors are essential for fetal-maternal connection and embryo viability.
Yang F; Huang L; Tso A; Wang H; Cui L; Lin L; Wang X; Ren M; Fang X; Liu J; Han Z; Chen J; Ouyang K
PLoS Genet; 2020 Apr; 16(4):e1008739. PubMed ID: 32320395
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility of HIF-1α heterozygous-null mice to cardiovascular malformations associated with maternal diabetes.
Bohuslavova R; Skvorova L; Sedmera D; Semenza GL; Pavlinkova G
J Mol Cell Cardiol; 2013 Jul; 60():129-41. PubMed ID: 23619295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
